• Products
  • Workflow Benefits
  • Science & Education
  • Introduction to liver disease management
  • Module 1: Hepatocellular carcinoma (HCC)
  • Module 2: Hepatic metastases
    • ConclusionsLexicon

Module 2:

Hepatic metastases

1. Detection and characterization

1.1. Context

  • Accurate detection of liver lesions and staging of liver disease can enable optimal treatment decision making and precise treatment planning, and can potentially avoid the devastating consequences of missed diagnoses, delayed treatment, or unnecessary interventions.
  • Magnetic resonance imaging (MRI) and computed tomography (CT) are the primary imaging modalities to detect metastases.
  • Dynamic contrast-enhanced MRI is more versatile than CT, providing functional as well as morphologic data.
Back
Next
    • 1
      Kaur H, Hindman NM, Al-Refaie WB, et al. ACR Appropriateness Criteria(®) suspected liver metastases. J Am Coll Radiol. 2017;14(5s):s314-s325.
    • 2
      Zech CJ, Justo N, Lang A, et al. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: results from the VALUE Trial. Eur Radiol. 2016;26(11):4121-4130.
    • 3
      Venkatesh SK, Chandan V, Roberts LR. Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol. 2014;12(9):1414-1429.
    • 4
      Zech CJ, Korpraphong P, Huppertz A, et al. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014;101(6):613-621.
    • 5
      Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422.
    • 6
      Floriani I, Torri V, Rulli E, et al. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010;31(1):19-31.
    • 7
      Van Cutsem E, Verheul HM, Flamen P, et al. Imaging in colorectal cancer: progress and challenges for the clinicians. Cancers (Basel). 2016;8(9):pii: E81.